[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f5D4pa5JMc6fxbolMuybs4mL-A-saT3vXtnOkxxOkKsM":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":48,"rows":55},"I.M. Sechenov First Moscow State Medical University",[4],132,false,24,1,39310,4,113,[14,17,19,22,24,26,28,30],{"name":15,"count":16},"Heart Failure",6,{"name":18,"count":16},"Coronary Artery Disease",{"name":20,"count":21},"COVID-19",5,{"name":23,"count":21},"Prostate Cancer",{"name":25,"count":11},"Arterial Hypertension",{"name":27,"count":11},"Quality of Life",{"name":29,"count":11},"Prostate Adenocarcinoma",{"name":31,"count":11},"Cardiovascular Diseases",[33,38,43],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT06458543","Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age","2025-06-01","Longidaza",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT07280364","Metabolomics in the Diagnosis and Treatment of Asthma in Children","2026-06","Standart medical treatment",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT06652087","Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction","2026-09-30","Rifaximin",[49,50,51,52,53,54],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[56,81,99,120,143,172,190,217,235,253,278,305,331,356,385,403,428,452,477,502,529,547,574,592,622,640,658,682],{"intervention":37,"totalTrials":9,"cells":57},{"EARLY_PHASE1":58,"PHASE1":61,"PHASE2":63,"PHASE3":65,"PHASE4":67,"NA":79},{"trials":59,"activeCount":60},[],0,{"trials":62,"activeCount":60},[],{"trials":64,"activeCount":60},[],{"trials":66,"activeCount":60},[],{"trials":68,"activeCount":9,"soonestReadout":36},[69],{"nctId":34,"briefTitle":35,"status":70,"phases":71,"primaryCompletion":36,"completion":72,"start":73,"enrollment":74,"conditions":75,"interventions":77},"RECRUITING",[53],"2026-06-01","2024-06-01",100,[76],"Bacterial Vaginosis",[37,78],"Metronidazole 500 mg",{"trials":80,"activeCount":60},[],{"intervention":78,"totalTrials":9,"cells":82},{"EARLY_PHASE1":83,"PHASE1":85,"PHASE2":87,"PHASE3":89,"PHASE4":91,"NA":97},{"trials":84,"activeCount":60},[],{"trials":86,"activeCount":60},[],{"trials":88,"activeCount":60},[],{"trials":90,"activeCount":60},[],{"trials":92,"activeCount":9,"soonestReadout":36},[93],{"nctId":34,"briefTitle":35,"status":70,"phases":94,"primaryCompletion":36,"completion":72,"start":73,"enrollment":74,"conditions":95,"interventions":96},[53],[76],[37,78],{"trials":98,"activeCount":60},[],{"intervention":42,"totalTrials":9,"cells":100},{"EARLY_PHASE1":101,"PHASE1":103,"PHASE2":105,"PHASE3":107,"PHASE4":109,"NA":111},{"trials":102,"activeCount":60},[],{"trials":104,"activeCount":60},[],{"trials":106,"activeCount":60},[],{"trials":108,"activeCount":60},[],{"trials":110,"activeCount":60},[],{"trials":112,"activeCount":9,"soonestReadout":41},[113],{"nctId":39,"briefTitle":40,"status":70,"phases":114,"primaryCompletion":41,"completion":115,"start":116,"enrollment":74,"conditions":117,"interventions":119},[],"2026-08","2024-03-13",[118],"Asthma",[42],{"intervention":47,"totalTrials":9,"cells":121},{"EARLY_PHASE1":122,"PHASE1":124,"PHASE2":126,"PHASE3":128,"PHASE4":130,"NA":132},{"trials":123,"activeCount":60},[],{"trials":125,"activeCount":60},[],{"trials":127,"activeCount":60},[],{"trials":129,"activeCount":60},[],{"trials":131,"activeCount":60},[],{"trials":133,"activeCount":9,"soonestReadout":46},[134],{"nctId":44,"briefTitle":45,"status":70,"phases":135,"primaryCompletion":46,"completion":136,"start":137,"enrollment":138,"conditions":139,"interventions":142},[54],"2027-09-30","2024-09-02",40,[140,141],"Bacterial Overgrowth Syndrome Small Bowel","Heart Failure with Preserved Ejection Fraction",[47],{"intervention":144,"totalTrials":9,"cells":145},"BUCCOTHERM® Sensitive Gums with Fluoride",{"EARLY_PHASE1":146,"PHASE1":148,"PHASE2":150,"PHASE3":152,"PHASE4":154,"NA":170},{"trials":147,"activeCount":60},[],{"trials":149,"activeCount":60},[],{"trials":151,"activeCount":60},[],{"trials":153,"activeCount":60},[],{"trials":155,"activeCount":60},[156],{"nctId":157,"briefTitle":158,"status":159,"phases":160,"primaryCompletion":161,"completion":162,"start":163,"enrollment":164,"conditions":165,"interventions":168},"NCT05623761","Toothpastes With Thermal Water for Oral Health","COMPLETED",[53],"2023-01-30","2023-02-15","2022-11-01",84,[166,167],"Gingivitis","Dentin Hypersensitivity",[144,169],"BUCCOTHERM® Sensitive Gums Fluoride-Free",{"trials":171,"activeCount":60},[],{"intervention":169,"totalTrials":9,"cells":173},{"EARLY_PHASE1":174,"PHASE1":176,"PHASE2":178,"PHASE3":180,"PHASE4":182,"NA":188},{"trials":175,"activeCount":60},[],{"trials":177,"activeCount":60},[],{"trials":179,"activeCount":60},[],{"trials":181,"activeCount":60},[],{"trials":183,"activeCount":60},[184],{"nctId":157,"briefTitle":158,"status":159,"phases":185,"primaryCompletion":161,"completion":162,"start":163,"enrollment":164,"conditions":186,"interventions":187},[53],[166,167],[144,169],{"trials":189,"activeCount":60},[],{"intervention":191,"totalTrials":9,"cells":192},"Dental foam \"Biorepair PERIBIOMA\"",{"EARLY_PHASE1":193,"PHASE1":195,"PHASE2":197,"PHASE3":199,"PHASE4":201,"NA":215},{"trials":194,"activeCount":60},[],{"trials":196,"activeCount":60},[],{"trials":198,"activeCount":60},[],{"trials":200,"activeCount":60},[],{"trials":202,"activeCount":60},[203],{"nctId":204,"briefTitle":205,"status":159,"phases":206,"primaryCompletion":207,"completion":207,"start":208,"enrollment":209,"conditions":210,"interventions":212},"NCT06148662","The Effect of Oral Sprays on Salivary pH",[53],"2024-01-25","2023-12-01",33,[211],"Oral Health",[191,213,214],"Dental foam \"WATER:DENT\"","Dental spray \"BUCCOTHERM\"",{"trials":216,"activeCount":60},[],{"intervention":213,"totalTrials":9,"cells":218},{"EARLY_PHASE1":219,"PHASE1":221,"PHASE2":223,"PHASE3":225,"PHASE4":227,"NA":233},{"trials":220,"activeCount":60},[],{"trials":222,"activeCount":60},[],{"trials":224,"activeCount":60},[],{"trials":226,"activeCount":60},[],{"trials":228,"activeCount":60},[229],{"nctId":204,"briefTitle":205,"status":159,"phases":230,"primaryCompletion":207,"completion":207,"start":208,"enrollment":209,"conditions":231,"interventions":232},[53],[211],[191,213,214],{"trials":234,"activeCount":60},[],{"intervention":214,"totalTrials":9,"cells":236},{"EARLY_PHASE1":237,"PHASE1":239,"PHASE2":241,"PHASE3":243,"PHASE4":245,"NA":251},{"trials":238,"activeCount":60},[],{"trials":240,"activeCount":60},[],{"trials":242,"activeCount":60},[],{"trials":244,"activeCount":60},[],{"trials":246,"activeCount":60},[247],{"nctId":204,"briefTitle":205,"status":159,"phases":248,"primaryCompletion":207,"completion":207,"start":208,"enrollment":209,"conditions":249,"interventions":250},[53],[211],[191,213,214],{"trials":252,"activeCount":60},[],{"intervention":254,"totalTrials":9,"cells":255},"Standard list of drugs used for acute decompensation of CHF",{"EARLY_PHASE1":256,"PHASE1":258,"PHASE2":260,"PHASE3":262,"PHASE4":264,"NA":276},{"trials":257,"activeCount":60},[],{"trials":259,"activeCount":60},[],{"trials":261,"activeCount":60},[],{"trials":263,"activeCount":60},[],{"trials":265,"activeCount":60},[266],{"nctId":267,"briefTitle":268,"status":159,"phases":269,"primaryCompletion":270,"completion":270,"start":271,"enrollment":272,"conditions":273,"interventions":275},"NCT04778787","Sodium-glucose Cotransporter Type 2 Inhibitors for Acute Cardiorenal Syndrome Prevention",[53],"2022-08-01","2021-01-01",370,[274],"Congestive Heart Failure",[254],{"trials":277,"activeCount":60},[],{"intervention":279,"totalTrials":9,"cells":280},"Tamsulosin Oral",{"EARLY_PHASE1":281,"PHASE1":283,"PHASE2":285,"PHASE3":287,"PHASE4":289,"NA":303},{"trials":282,"activeCount":60},[],{"trials":284,"activeCount":60},[],{"trials":286,"activeCount":60},[],{"trials":288,"activeCount":60},[],{"trials":290,"activeCount":60},[291],{"nctId":292,"briefTitle":293,"status":159,"phases":294,"primaryCompletion":295,"completion":295,"start":296,"enrollment":297,"conditions":298,"interventions":302},"NCT03856242","Benign Prostatic Hyperplasia and Ischemic Heart DIsease",[53],"2017-09-01","2015-09-01",83,[299,300,301],"Ischaemic Heart Disease (IHD)","Benign Prostatic Hyperplasia (BPH)","Lower Urinary Tract Symptoms (LUTS)",[279],{"trials":304,"activeCount":60},[],{"intervention":306,"totalTrials":9,"cells":307},"prescribing anapproved drug, examination",{"EARLY_PHASE1":308,"PHASE1":310,"PHASE2":312,"PHASE3":314,"PHASE4":316,"NA":329},{"trials":309,"activeCount":60},[],{"trials":311,"activeCount":60},[],{"trials":313,"activeCount":60},[],{"trials":315,"activeCount":60},[],{"trials":317,"activeCount":60},[318],{"nctId":319,"briefTitle":320,"status":321,"phases":322,"primaryCompletion":323,"completion":323,"start":324,"enrollment":325,"conditions":326,"interventions":328},"NCT05379036","Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome","UNKNOWN",[53],"2022-05-31","2021-06-23",60,[327],"Irritable Bowel Syndrome With Diarrhea",[306],{"trials":330,"activeCount":60},[],{"intervention":332,"totalTrials":9,"cells":333},"Hygienic procedure",{"EARLY_PHASE1":334,"PHASE1":336,"PHASE2":338,"PHASE3":340,"PHASE4":342,"NA":354},{"trials":335,"activeCount":60},[],{"trials":337,"activeCount":60},[],{"trials":339,"activeCount":60},[],{"trials":341,"activeCount":60},[],{"trials":343,"activeCount":60},[344],{"nctId":345,"briefTitle":346,"status":159,"phases":347,"primaryCompletion":348,"completion":349,"start":350,"enrollment":351,"conditions":352,"interventions":353},"NCT04896294","Ca-hydroxyapatite, Fluoroapatite, and Mg-Zn-hydroxyapatite for Dentin Hypersensitivity Management",[53],"2021-06-21","2021-07-19","2021-04-24",30,[167],[332,332,332],{"trials":355,"activeCount":60},[],{"intervention":357,"totalTrials":9,"cells":358},"mycophenolate mofetil 2 g per day",{"EARLY_PHASE1":359,"PHASE1":361,"PHASE2":363,"PHASE3":365,"PHASE4":381,"NA":383},{"trials":360,"activeCount":60},[],{"trials":362,"activeCount":60},[],{"trials":364,"activeCount":60},[],{"trials":366,"activeCount":60},[367],{"nctId":368,"briefTitle":369,"status":159,"phases":370,"primaryCompletion":371,"completion":371,"start":372,"enrollment":373,"conditions":374,"interventions":379},"NCT05237323","Micophenolate Mofetil Versus Azathioprine in Myocarditis",[52],"2025-07-10","2020-10-01",50,[375,15,376,377,378],"Lymphocytic Myocarditis (Disorder)","Dilated Cardiomyopathy","Cardiomyopathies","Sudden Cardiac Death",[357,380],"azathioprine of 150 [75; 150] mg per day",{"trials":382,"activeCount":60},[],{"trials":384,"activeCount":60},[],{"intervention":380,"totalTrials":9,"cells":386},{"EARLY_PHASE1":387,"PHASE1":389,"PHASE2":391,"PHASE3":393,"PHASE4":399,"NA":401},{"trials":388,"activeCount":60},[],{"trials":390,"activeCount":60},[],{"trials":392,"activeCount":60},[],{"trials":394,"activeCount":60},[395],{"nctId":368,"briefTitle":369,"status":159,"phases":396,"primaryCompletion":371,"completion":371,"start":372,"enrollment":373,"conditions":397,"interventions":398},[52],[375,15,376,377,378],[357,380],{"trials":400,"activeCount":60},[],{"trials":402,"activeCount":60},[],{"intervention":404,"totalTrials":9,"cells":405},"Zopiclone",{"EARLY_PHASE1":406,"PHASE1":408,"PHASE2":410,"PHASE3":422,"PHASE4":424,"NA":426},{"trials":407,"activeCount":60},[],{"trials":409,"activeCount":60},[],{"trials":411,"activeCount":60},[412],{"nctId":413,"briefTitle":414,"status":159,"phases":415,"primaryCompletion":416,"completion":416,"start":417,"enrollment":418,"conditions":419,"interventions":421},"NCT03339583","Effectiveness of BBT-I and Zopiclone for Chronic Insomnia",[51],"2017-03-14","2015-04-07",42,[420],"Insomnia Chronic",[404],{"trials":423,"activeCount":60},[],{"trials":425,"activeCount":60},[],{"trials":427,"activeCount":60},[],{"intervention":429,"totalTrials":9,"cells":430},"Colchicine",{"EARLY_PHASE1":431,"PHASE1":433,"PHASE2":435,"PHASE3":446,"PHASE4":448,"NA":450},{"trials":432,"activeCount":60},[],{"trials":434,"activeCount":60},[],{"trials":436,"activeCount":60},[437],{"nctId":438,"briefTitle":439,"status":159,"phases":440,"primaryCompletion":441,"completion":441,"start":442,"enrollment":418,"conditions":443,"interventions":445},"NCT05637398","Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction",[50,51],"2025-09-01","2022-12-15",[444,429],"HFpEF - Heart Failure With Preserved Ejection Fraction",[429],{"trials":447,"activeCount":60},[],{"trials":449,"activeCount":60},[],{"trials":451,"activeCount":60},[],{"intervention":453,"totalTrials":9,"cells":454},"Tofacitinib",{"EARLY_PHASE1":455,"PHASE1":457,"PHASE2":459,"PHASE3":471,"PHASE4":473,"NA":475},{"trials":456,"activeCount":60},[],{"trials":458,"activeCount":60},[],{"trials":460,"activeCount":60},[461],{"nctId":462,"briefTitle":463,"status":159,"phases":464,"primaryCompletion":465,"completion":466,"start":467,"enrollment":468,"conditions":469,"interventions":470},"NCT04750317","Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia",[51],"2020-08-01","2020-09-01","2020-05-11",414,[20],[453],{"trials":472,"activeCount":60},[],{"trials":474,"activeCount":60},[],{"trials":476,"activeCount":60},[],{"intervention":478,"totalTrials":9,"cells":479},"Methylene Blue and Photodynamic Therapy",{"EARLY_PHASE1":480,"PHASE1":482,"PHASE2":494,"PHASE3":496,"PHASE4":498,"NA":500},{"trials":481,"activeCount":60},[],{"trials":483,"activeCount":60},[484],{"nctId":485,"briefTitle":486,"status":159,"phases":487,"primaryCompletion":488,"completion":489,"start":490,"enrollment":325,"conditions":491,"interventions":493},"NCT04933864","COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy",[50],"2020-05-20","2020-07-30","2020-04-24",[492],"SARS-CoV-2",[478],{"trials":495,"activeCount":60},[],{"trials":497,"activeCount":60},[],{"trials":499,"activeCount":60},[],{"trials":501,"activeCount":60},[],{"intervention":503,"totalTrials":9,"cells":504},"thyroxine",{"EARLY_PHASE1":505,"PHASE1":507,"PHASE2":509,"PHASE3":511,"PHASE4":513,"NA":515},{"trials":506,"activeCount":60},[],{"trials":508,"activeCount":60},[],{"trials":510,"activeCount":60},[],{"trials":512,"activeCount":60},[],{"trials":514,"activeCount":60},[],{"trials":516,"activeCount":60},[517],{"nctId":518,"briefTitle":519,"status":159,"phases":520,"primaryCompletion":521,"completion":522,"start":523,"enrollment":524,"conditions":525,"interventions":527},"NCT00715572","Combined Therapy With L-Thyroxine and L-Triiodothyronine Compared to L-Thyroxine Alone",[54],"2004-02","2004-05","2002-03",36,[526],"Hypothyroidism",[503,528],"thyroxine and triiodothyronine",{"intervention":528,"totalTrials":9,"cells":530},{"EARLY_PHASE1":531,"PHASE1":533,"PHASE2":535,"PHASE3":537,"PHASE4":539,"NA":541},{"trials":532,"activeCount":60},[],{"trials":534,"activeCount":60},[],{"trials":536,"activeCount":60},[],{"trials":538,"activeCount":60},[],{"trials":540,"activeCount":60},[],{"trials":542,"activeCount":60},[543],{"nctId":518,"briefTitle":519,"status":159,"phases":544,"primaryCompletion":521,"completion":522,"start":523,"enrollment":524,"conditions":545,"interventions":546},[54],[526],[503,528],{"intervention":548,"totalTrials":9,"cells":549},"moderate propofol sedation (Bispectral index monitoring 70-90; The Richmond Agitation and Sedation scale (RASS) \"-2\" - \"-3\"",{"EARLY_PHASE1":550,"PHASE1":552,"PHASE2":554,"PHASE3":556,"PHASE4":558,"NA":560},{"trials":551,"activeCount":60},[],{"trials":553,"activeCount":60},[],{"trials":555,"activeCount":60},[],{"trials":557,"activeCount":60},[],{"trials":559,"activeCount":60},[],{"trials":561,"activeCount":60},[562],{"nctId":563,"briefTitle":564,"status":159,"phases":565,"primaryCompletion":566,"completion":567,"start":568,"enrollment":8,"conditions":569,"interventions":572},"NCT04695509","Sedation and Neuromediators Concentration",[54],"2021-01-15","2021-04-15","2020-10-05",[570,571],"Moderate Sedation","Deep Sedation",[548,573],"deep propofol sedation",{"intervention":573,"totalTrials":9,"cells":575},{"EARLY_PHASE1":576,"PHASE1":578,"PHASE2":580,"PHASE3":582,"PHASE4":584,"NA":586},{"trials":577,"activeCount":60},[],{"trials":579,"activeCount":60},[],{"trials":581,"activeCount":60},[],{"trials":583,"activeCount":60},[],{"trials":585,"activeCount":60},[],{"trials":587,"activeCount":60},[588],{"nctId":563,"briefTitle":564,"status":159,"phases":589,"primaryCompletion":566,"completion":567,"start":568,"enrollment":8,"conditions":590,"interventions":591},[54],[570,571],[548,573],{"intervention":593,"totalTrials":9,"cells":594},"Influence of propofol sedation on memory consolidation and 'working memory'",{"EARLY_PHASE1":595,"PHASE1":597,"PHASE2":599,"PHASE3":601,"PHASE4":603,"NA":605},{"trials":596,"activeCount":60},[],{"trials":598,"activeCount":60},[],{"trials":600,"activeCount":60},[],{"trials":602,"activeCount":60},[],{"trials":604,"activeCount":60},[],{"trials":606,"activeCount":60},[607],{"nctId":608,"briefTitle":609,"status":159,"phases":610,"primaryCompletion":611,"completion":611,"start":612,"enrollment":613,"conditions":614,"interventions":619},"NCT05045170","Sedation and Memory Consolidation",[54],"2022-01-13","2021-05-11",81,[615,616,617,618],"Memory Impairment","Amnesia","Recall","Recognition",[593,620,621],"Influence of dexmedetomidine sedation on memory consolidation and 'working memory'","Influence of spinal anesthesia on memory consolidation and 'working memory'",{"intervention":620,"totalTrials":9,"cells":623},{"EARLY_PHASE1":624,"PHASE1":626,"PHASE2":628,"PHASE3":630,"PHASE4":632,"NA":634},{"trials":625,"activeCount":60},[],{"trials":627,"activeCount":60},[],{"trials":629,"activeCount":60},[],{"trials":631,"activeCount":60},[],{"trials":633,"activeCount":60},[],{"trials":635,"activeCount":60},[636],{"nctId":608,"briefTitle":609,"status":159,"phases":637,"primaryCompletion":611,"completion":611,"start":612,"enrollment":613,"conditions":638,"interventions":639},[54],[615,616,617,618],[593,620,621],{"intervention":621,"totalTrials":9,"cells":641},{"EARLY_PHASE1":642,"PHASE1":644,"PHASE2":646,"PHASE3":648,"PHASE4":650,"NA":652},{"trials":643,"activeCount":60},[],{"trials":645,"activeCount":60},[],{"trials":647,"activeCount":60},[],{"trials":649,"activeCount":60},[],{"trials":651,"activeCount":60},[],{"trials":653,"activeCount":60},[654],{"nctId":608,"briefTitle":609,"status":159,"phases":655,"primaryCompletion":611,"completion":611,"start":612,"enrollment":613,"conditions":656,"interventions":657},[54],[615,616,617,618],[593,620,621],{"intervention":659,"totalTrials":9,"cells":660},"Saccharomyces Boulardii Probiotic Supplement",{"EARLY_PHASE1":661,"PHASE1":663,"PHASE2":665,"PHASE3":667,"PHASE4":669,"NA":671},{"trials":662,"activeCount":60},[],{"trials":664,"activeCount":60},[],{"trials":666,"activeCount":60},[],{"trials":668,"activeCount":60},[],{"trials":670,"activeCount":60},[],{"trials":672,"activeCount":60},[673],{"nctId":674,"briefTitle":675,"status":159,"phases":676,"primaryCompletion":677,"completion":677,"start":678,"enrollment":138,"conditions":679,"interventions":681},"NCT05231772","Probiotics and Hemodynamic Changes in Cirrhosis",[54],"2022-03-29","2021-03-01",[680],"Cirrhosis",[659],{"intervention":683,"totalTrials":9,"cells":684},"Atorvastatin",{"EARLY_PHASE1":685,"PHASE1":687,"PHASE2":689,"PHASE3":691,"PHASE4":693,"NA":695},{"trials":686,"activeCount":60},[],{"trials":688,"activeCount":60},[],{"trials":690,"activeCount":60},[],{"trials":692,"activeCount":60},[],{"trials":694,"activeCount":60},[],{"trials":696,"activeCount":60},[697],{"nctId":698,"briefTitle":699,"status":159,"phases":700,"primaryCompletion":701,"completion":702,"start":703,"enrollment":704,"conditions":705,"interventions":707},"NCT04666389","The Role of Statins in the Prevention of Contrast-induced Acute Kidney Injury in Patients With Cardiovascular Diseases",[54],"2022-12-31","2023-01-10","2020-10-15",150,[706,31],"Contrast-induced Acute Kidney Injury",[683]]